Sarcoma
Volume 2008 (2008), Article ID 854141, 4 pages
doi:10.1155/2008/854141
Case Report

Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal Therapy

J. Thariat,1 A. Italiano,2 F. Peyrade,3 I. Birtwisle-Peyrottes,4 L. Gastaud,3 O. Dassonville,5 and A. Thyss3

1Department of Radiation Oncology, Centre Antoine Lacassagne, 33 avenue de Valombrose, 06189 NICE Cedex 2, France
2Department of Cytogenetics, Centre Antoine Lacassagne, 33 avenue de Valombrose, 06189 NICE Cedex 2, France
3Department of Medical Oncology, Centre Antoine Lacassagne, 33 avenue de Valombrose, 06189 NICE Cedex 2, France
4Departement of Pathology, Centre Antoine Lacassagne, 33 avenue de Valombrose, 06189 NICE Cedex 2, France
5Department of Head and Neck Surgery, Centre Antoine Lacassagne, 33 avenue de Valombrose, 06189 NICE Cedex 2, France

Received 6 December 2007; Revised 1 March 2008; Accepted 28 April 2008

Academic Editor: Chandrajit Raut

Copyright © 2008 J. Thariat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. C. Daw, H. H. Mahmoud, W. H. Meyer, et al., “Bone sarcomas of the head and neck in children: the St. Jude Children's Research Hospital experience,” Cancer, vol. 88, no. 9, pp. 2172–2180, 2000. View at Publisher · View at Google Scholar
  2. B. U. Coskun, U. Cinar, H. Savk, T. Basak, and B. Dadas, “Isolated maxillary sinus Ewing's sarcoma,” Rhinology, vol. 43, no. 3, pp. 225–228, 2005.
  3. J. Dunst, S. Ahrens, M. Paulussen, et al., “Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies,” International Journal of Radiation Oncology Biology Physics, vol. 42, no. 2, pp. 379–384, 1998. View at Publisher · View at Google Scholar
  4. K. Fizazi, N. Dohollou, J.-Y. Blay, et al., “Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients,” Journal of Clinical Oncology, vol. 16, no. 12, pp. 3736–3743, 1998.
  5. T. W. McLean, C. Hertel, M. L. Young, et al., “Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience,” Journal of Pediatric Hematology/Oncology, vol. 21, no. 6, pp. 486–493, 1999.
  6. B. R. Prestidge and S. S. Donaldson, “Treatment results among adults with childhood tumors: a 20-year experience,” International Journal of Radiation Oncology Biology Physics, vol. 17, no. 3, pp. 507–514, 1989.
  7. EUROEWING, 1999, http://www.clinicaltrials.gov/ct2/show/NCT00020566?term=euro+ewing&rank=1.
  8. H. Jürgens, A. Ranft, U. Dirksen, et al., “Risks of recurrence and survival after relapse in patients with Ewing tumor,” Journal of Clinical Oncology, vol. 25, no. 18S, supplement, 2007, 10012.
  9. C. Rodríguez-Galindo, T. Liu, M. J. Krasin, et al., “Analysis of prognostic factors in Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies,” Cancer, vol. 110, no. 2, pp. 375–384, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. G. P. Siegal, W. R. Oliver, W. R. Reinus, et al., “Primary Ewing's sarcoma involving the bones of the head and neck,” Cancer, vol. 60, no. 11, pp. 2829–2840, 1987. View at Publisher · View at Google Scholar
  11. R. C. Shamberger, M. P. LaQuaglia, M. C. Gebhardt, et al., “Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy,” Annals of Surgery, vol. 238, no. 4, pp. 563–568, 2003.
  12. G. Zogopoulos, L. Teskey, L. Sung, et al., “Ewing sarcoma: favourable results with combined modality therapy and conservative use of radiotherapy,” Pediatric Blood and Cancer, vol. 43, no. 1, pp. 35–39, 2004. View at Publisher · View at Google Scholar · View at PubMed
  13. A. M. McTiernan, A. M. Cassoni, D. Driver, M. P. Michelagnoli, A. M. Kilby, and J. S. Whelan, “Improving outcomes after relapse in Ewing's sarcoma: analysis of 114 patients from a single institution,” Sarcoma, vol. 2006, Article ID 83548, 8 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
  14. A. C. Pauline, “Collins' law revisited: can we reliably predict the time to recurrence in common pediatric tumors?,” Pediatric Hematology and Oncology, vol. 23, no. 1, pp. 81–86, 2006. View at Publisher · View at Google Scholar · View at PubMed
  15. P. Leavey, L. Mascarenhas, N. Marina, et al., “Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence,” Journal of Clinical Oncology, vol. 25, no. 18S, supplement, 2007, 10011.
  16. G. Bacci, A. Longhi, S. Ferrari, et al., “Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999,” European Journal of Surgical Oncology, vol. 32, no. 9, pp. 974–979, 2006. View at Publisher · View at Google Scholar · View at PubMed